Patents by Inventor Gema Ruano Plaza

Gema Ruano Plaza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 6-METHOXY-3,4-DIHYDRO-1H-ISOQUINOLIN COMPOUNDS
    Publication number: 20230373927
    Abstract: In an embodiment, the present invention provides a compound of the formula: wherein R1 is selected from the group consisting of F and H; R2 is selected from the group consisting of CH3, CH3CHCH3 and —NHCH2CH(CH3)2; R3 is selected from the group consisting of H and —CH2OCH3; R4 is selected from the group consisting of H and CH3; R5 is selected from the group consisting of H and CH3; R6 is selected from the group consisting of H and OH; R7 is selected from the group consisting of or a pharmaceutically acceptable salt thereof, and methods of using this compound for positive allosteric modulation of a receptor selected from the group consisting of GLP1, GIP, and glucagon.
    Type: Application
    Filed: October 6, 2021
    Publication date: November 23, 2023
    Inventors: Ana Belén BUENO MELENDO, Jayana Pankajkumar LINESWALA, Gema RUANO PLAZA, Nuria Diaz BUEZO
  • PYRIMIDINE-5-CARBOXAMIDE COMPOUND
    Publication number: 20220274933
    Abstract: The present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type 2 diabetes mellitus.
    Type: Application
    Filed: July 31, 2020
    Publication date: September 1, 2022
    Inventor: Sra. Gema RUANO PLAZA
  • Ghrelin 0-acyl transferase inhibitors
    Patent number: 10227310
    Abstract: The present invention provides novel GOAT inhibitors and their salts and pharmaceutical compositions thereof.
    Type: Grant
    Filed: April 13, 2016
    Date of Patent: March 12, 2019
    Assignee: Eli Lilly and Company
    Inventors: Christopher Stanley Galka, Erik James Hembre, Nicholas Allan Honigschmidt, Maria Angeles Martinez-Grau, Gema Ruano Plaza, Almudena Rubio, Stacy Jo Keding, Daryl Lynn Smith
  • Ghrelin O-acyl transferase inhibitors
    Patent number: 10093651
    Abstract: The present invention provides novel GOAT inhibitors and their salts and pharmaceutical compositions thereof.
    Type: Grant
    Filed: April 13, 2016
    Date of Patent: October 9, 2018
    Assignee: Eli Lilly and Company
    Inventors: Christopher Stanley Galka, Erik James Hembre, Nicholas Allan Honigschmidt, Maria Angeles Martinez-Grau, Gema Ruano Plaza, Almudena Rubio
  • GHRELIN 0-ACYL TRANSFERASE INHIBITORS
    Publication number: 20180086732
    Abstract: The present invention provides novel GOAT inhibitors and their salts and pharmaceutical compositions thereof.
    Type: Application
    Filed: April 13, 2016
    Publication date: March 29, 2018
    Inventors: Christopher Stanley Galka, Erik James Hembre, Nicholas Allan Honigschmidt, Maria Angeles Martinez-Grau, Gema Ruano Plaza, Almudena Rubio
  • GHRELIN 0-ACYL TRANSFERASE INHIBITORS
    Publication number: 20180079729
    Abstract: The present invention provides novel GOAT inhibitors and their salts and pharmaceutical compositions thereof.
    Type: Application
    Filed: April 13, 2016
    Publication date: March 22, 2018
    Inventors: Christopher Stanley Galka, Erik James Hembre, Nicholas Allan Honigschmidt, Maria Angeles Martinez-Grau, Gema Ruano Plaza, Almudena Rubio, Stacy Jo Keding, Daryl Lynn Smith